Aim: To develop a periodontal pocket drug delivery system of cefixime loaded ethyl cellulose (EC) strips using hydroxypropyl cellulose (HPC), hydroxypropylmethyl cellulose K 4 M (HPMC K 4 M), and Eudragit RL-100 as copolymers with different concentrations. Materials and Methods: Casting/solvent technique was utilized to prepared strips. The prepared strips were evaluated for physicochemical parameters such as Fourier transform infrared spectroscopy (FT-IR), thickness, folding endurance, percentage moisture loss, content uniformity, in-vitro drug release, and in-vitro antibacterial activity. Results and Discussion: FT-IR data showed that drug and excipients were compatible with each other. The formulated strips were flexible, having uniform drug content, and exhibited acceptable physicochemical characteristics. The drug release was sustained for up to 5 days, even if the strips demonstrated initial burst effect. As formulation P 3 showed better drug release profile, was optimized among all other formulations. Conclusion: The present work proposes that the sustained release cefixime loaded EC strips with copolymer HPMC K 4 M have a significant role in the treatment of chronic periodontitis.
INTRODUCTION
T he inflammatory process and the immune response are involved in the periodontal infection. Periodontal destruction occurs mainly due to the presence of periodontal pathogens such as Prevotella intermedia, Porphyromonas gingivalis, and Actinobacillus actinomycetemcomitans. As the soft tissues surrounding, the teeth are affected by these pathogens and may lead to produce acute and chronic disorder. Finally, it may cause loss of supporting bones. [1] In general, periodontitis treatment involves scaling and planning, systemic antibiotic therapy. [2] Clinically and microbiologically, positive effects were demonstrated by some systemic antimicrobials, which additions to mechanical therapy. [3] Subinhibitory concentrations at the periodontal site may produce resistance in periodontal pathogens and create depressing impact toward these approaches. Periodontal pocket delivery systems acquire beneficial advantage because of this kind of negative effect. These delivery systems can locally provide inhibitory concentrations toward the periodontal pathogens of the drug for several days. Periodontal fibers, [4] strips, [5] and gels [6] were already studied.
Certain biodegradable polymers were utilized as drug transporters such as polyester poly (caprolactone), crosslinked atelocollagen, poly (gylcolidecold-lactide), glycerol monooleate, and hydroxyl-propylcellulose.
In the present work, the goal was to formulate periodontal pocket delivery system containing cefixime, dispersed in ethyl cellulose (EC), and various copolymers mixtures in different concentrations. Formulated strips were cut into the specified shape and size to make easy insert into the periodontal pocket.
Dental dosage form using EC has been recently demonstrated to sustain the release of drugs. [7, 8] EC has proved itself to use as modified release tablet matrix, [9] as a sustained release film former, and as a thickening agent, [10] and when the nonionic material is desired for oral as well as topical applications, as a stabilizer and suspending agent. [11] Hydroxypropyl cellulose (HPC), hydroxypropyl methylcellulose K 4 M (HPMC K 4 M), and Eudragit RL-100 copolymers have already been used as excipients of sustained release implant material in dentistry. [12] Cefixime is a third generation broad spectrum cephalosporin. It is used to treat infections of ear, sinuses, throat, chest, and lungs. In addition, it has been demonstrated to treat typhoid fever. [13] 
MATERIALS AND METHODS
EC, Ѵ 10 mPa.s, Eudragit RL-100, M r ~32,000, HPMC K 4 M, M r ~90,000, dichloromethane, M r 84.93, and methanol, M r 32.04, were purchased from Sigma-Aldrich, India; dibutylphthalate, M r 278.34, and HPC, M r 100,000 were purchased from Loba Chemicals, Mumbai, India; Cefixime, M r 453.452, was granted by Zydus Cadila Health Care Ltd., Ahmedabad, India; Mutans-Sanguis Agar, pH 7.10-7.50, was purchased from HiMedia Laboratories, Mumbai, India; all reagents were of analytical grade.
Preparation of cefixime strips
To obtain periodontal strips of fixed area (20 cm 2 ), casting/ solvent technique using methanol and dichloromethane (1:1) mixture, was utilized. To optimize polymer, copolymer, and plasticizer concentrations, total 24 preliminary batches [ Table 1 ] were formulated using 2 3 factorial design. In this, the polymer (EC, X 1 ), Copolymers (HPC, X 2 , HPMC K 4 M, X 3 and Edragit RL-100, X 4 ) and plasticizer (dibutyl phthalate, X 5 ) were selected as independent variables. On the basis of folding endurance results, finally total six formulations [ Table 2 ] were prepared.
To formulate dental implants, dissolving polymer and copolymer in methanol and dichloromethane (1:1) mixture, dibutylphalate (50% v/w of that polymer) was added as a plasticizer, using magnetic stirrer in a closed beaker. Into this, accurately 40 mg of cefixime was added. After absolute mixing, 10 ml of solution was poured into a clean glass Petri dish (Anumbra ® -area 60.6 cm 2 approximately), to be found on a horizontal plane and set aside at 30°C, by inverting glass funnel with a cotton plug closed in the stalk of funnel on Petri dish, for at least 24 h to permit total evaporation of solvent. Casted strips were cut with sharp knife into pieces of 0.5×0.4 cm 2 , enfolded with aluminum foil, accrued in desiccators at room temperature in dark place for further use. With the help of gas chromatography, solvent residues were determined for methanol.
Characterization of strips
With the help of Fourier transform infrared (FT-IR) spectroscopy compatibility of drug and excipients were carried out. Various physicochemical properties such as thickness, folding endurance, percentage moisture loss, content uniformity, in-vitro drug release, and in-vitro antibacterial activity were determined.
Infrared absorption spectroscopy (IR)
Samples of pure cefixime powder, cefixime, and all excipients were triturated with KBr in equal quantity and compressed with the help of hydraulic pressure to prepare discs for IR analysis. To obtain spectra, these discs were scanned using IR-spectrophotometer (Bruker Optics, Germany) over 400-4000 cm 
Measurement of strip thickness
According to American Academy of periodontology, chronic form of periodontitis contains 3-4mm pocket depth. So, for compatibility reason, it was necessary to formulate appropriate thickness containing strip. Therefore, electronic outside micrometer (Model IP54, Beijing C&C Trade Center, China) was used to carry outstrips thickness. Randomly selected three points from the strips were considered to determine thickness. Mean of three times measurements was considered as the result.
Uniformity of weight
Single pan balance was utilized to measure weight of individual 20 strips (0.6×0.5 cm 2 ) from all the formulations. The average weights of these strips were calculated, and the standard deviation was taken.
Folding endurance
To handle and during inserting dental strip into the periodontal pocket, appropriate folding endurance is required. The low value of it may create problems as well as the high value may cause increases in brittleness. To determine folding endurance, repeatedly folding a strip (2×2 cm 2 ) at the same place till it broke. [14] The total number of times, without breaking, the strip was folded at the same place, represent the folding endurance value.
Percentage moisture loss
Weighed pieces of the strip were kept in a desiccator containing anhydrous calcium chloride at room temperature in dark place. After three successive days, the strips were taken out and re-weighed. The % moisture loss was calculated from the weight decrease, as follows:
Where, W 1 and W 2 are the weight of the strip before and after kept in desiccator, respectively.
Content uniformity
Cefixime content determined by dissolving three weighed strips separately in 10 ml of dichloromethane. [15] . The drug was extracted with two consecutive quantities, each of 10 ml isotonic saline phosphate buffer pH 6.8 using separating funnel. The separation of the aqueous phase was done, and suitable dilution was made. Using UV-spectrophotometer (UV-1800, Shimadzu, Japan), absorbance was measured at 288.8 nm for cefixime.
In-vitro release studies
Cefixime release form the strips was determined by utilizing glass vial using 1 ml isotonic saline phosphate buffer pH 6.8 as dissolution medium at 37°C. 1 ml dissolution medium was withdrawn at every 24 h interval and to maintain "sink conditions" immediately replaced it with fresh 1 ml dissolution medium. [16] UV-spectrophotometric analysis at 288.8 nm was carried out to determine the amount of drug release, with suitable dilution of dissolution medium. 
In-vitro antibacterial activity
To determine in-vitro antibacterial activity of all formulations, strip was cut into 0.5×0.5 cm 2 . This cut strip was placed on Mutans-Sanguis Agar plates, seeded with the facultative anaerobic organisms, Streptococcus mutans at 37°C in biological oxygen demand incubator (Alliance Enterprise, Vadodara). Zone of inhibition was measured after 48 h. From this plate, strip was taken out and placed on another Mutans-Sanguis Agar plates having fresh seeding of organisms and incubated for 48 h at 37°C. This procedure was repeated till no inhibition was obtained. [17, 18] 
RESULTS AND DISCUSSION
The FT-IR data showed that drug and all excipients were compatible with each other, as there is no any interaction occurs ( Figure 1 ). Folding endurance of preliminary formulations A 1 , B 3 , and C 5 were found to be in acceptable limit (between 150 and 300). So, finally total 6 formulations were formulated.
The physical parameters such as thickness, folding endurance, percentage moisture loss, and content uniformity were described in Table 3 . The casted strips showed excellent strip forming properties as well as reproducibility. Formulated strips have flexibility, elasticity, and smooth surface. All formulations have percentage moisture loss between the ranges of 1.21-2.18. Formulation P 5 contains HPMC K 4 M alone, which has moisture loss property on storage. So, it exhibited high percentage moisture loss. In case of formulation P 1 , has low percentage moisture loss due to hydrophobic nature of EC. Drug content of all formulated strips was in the range of 96.6-97.9. This clearly stated that uniform distribution of drug in all the formulations. Highest drug content uniformity showed in P 3 , whereas lowest drug content uniformity in P 5 (Table 3 ). Figure 2 represents that in first 24 h, all strips showed rapid release of drug. It has been due to burst effect, as because of the outer surface of strips have quick elution and sharp cut edge of the strips matrix. After completion of burst effect, slowly sustained release of drug was seen up to 5 days. To recognized drug release profile as well as release mechanism, the in-vitro dissolution data were treated according to cumulative percentage of drug remaining versus time (Zero order), log cumulative percentage of drug remaining versus time (First order), cumulative percentage of drug release versus square root of time (Higuchi's equation) and Peppas equation. From the kinetic analysis of in-vitro drug release, Peppas model was best fitted to release mechanism of all the strips due to high linearity of plots. Comparison of regression coefficients and slopes was made in Table 4 . Figure 3 shows a comparison of zone of inhibition of all cefixime strips. Longer period antibacterial activity was obtained through formulation P 1 , P 2 , P 3 , and P 6 (6 days) then formulation P 4 and P 5 (4 days), as they have not contained EC. This might be due to less numbers of pore channels.
CONCLUSION AND FUTURE PERSPECTIVES
Periodontal pocket drug delivery system has a great advantage against systematic drug therapy is that the physicochemical properties. Strips showed sustained release of drug for up to 5 days followed by initial burst release of drug. From all the formulations, P 3 formulation containing 1.6% EC and 0.05% HPMC K 4 M showed release of drug and in-vitro antibacterial activity up to 120 and 144 h, respectively. The amount of residual methanol was found to be acceptable limit (689.5 ppm = < 3,000 ppm).
Finally, it is concluded that local therapy of periodontitis with the help of cefixime loaded EC strips has a remarkable role. In addition to this, it is cost-effective and will not interfere with a daily routine habit of patients. Incorporation of crosslinking of strips with support of suitable agent may increase the sustain release property of drug for several number of days. 
